Advisors Asset Management, Inc. Teva Pharmaceutical Industries LTD Transaction History

Advisors Asset Management, Inc.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 07, 2021	SELL	$10.34 - $12.81 $13,245 - $16,409	-1,281 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$8.61 - $11.04 $43,351 - $55,586	-5,035 Reduced 79.72%	1,281 $12,000
Q3 2020 Nov 16, 2020	SELL	$8.57 - $12.69 $6,761 - $10,012	-789 Reduced 11.1%	6,316 $57,000
Q2 2020 Aug 12, 2020	SELL	$8.12 - $13.12 $4,279 - $6,914	-527 Reduced 6.91%	7,105 $88,000
Q1 2020 May 15, 2020	SELL	$6.69 - $13.45 $990 - $1,990	-148 Reduced 1.9%	7,632 $69,000
Q4 2019 Feb 14, 2020	SELL	$6.53 - $10.72 $339 - $557	-52 Reduced 0.66%	7,780 $76,000
Q3 2019 Nov 14, 2019	BUY	$6.16 - $9.6 $252 - $393	41 Added 0.53%	7,832 $54,000
Q2 2019 Aug 14, 2019	BUY	$8.12 - $15.72 $12,147 - $23,517	1,496 Added 23.76%	7,791 $72,000
Q1 2019 May 15, 2019	SELL	$15.58 - $20.01 $59,235 - $76,078	-3,802 Reduced 37.65%	6,295 $99,000
Q4 2018 Jan 31, 2019	SELL	$14.59 - $23.84 $6,725 - $10,990	-461 Reduced 4.37%	10,097 $156,000
Q3 2018 Nov 15, 2018	SELL	$21.06 - $25.65 $406,184 - $494,711	-19,287 Reduced 64.62%	10,558 $227,000
Q2 2018 Aug 22, 2018	BUY	$16.77 - $24.71 $436,942 - $643,819	26,055 Added 687.47%	29,845 $726,000
Q2 2018 Aug 15, 2018	SELL	$16.77 - $24.71 $506,152 - $745,797	-30,182 Reduced 88.84%	3,790 $726,000
Q1 2018 May 15, 2018	SELL	$16.68 - $22.07 $11,325 - $14,985	-679 Reduced 1.96%	33,972 $636,000
Q4 2017 Feb 13, 2018	SELL	$11.23 - $19.1 $47,716 - $81,155	-4,249 Reduced 10.92%	34,651 $657,000
Q3 2017 Nov 07, 2017	BUY	$15.41 - $32.17 $599,449 - $1.25 Million	38,900	38,900 $685,000

617

563M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisors Asset Management, Inc. with notifications on news.